Galectin-3 and cancer mortality in patients with suspected or known coronary artery disease: the ANOX study

1 September 2024 (11:00 - 11:40)
Organised by: Logo
Congress Presentation Part of: Complexities in coronary artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by